Angiodynamics (ANGO) Equity Average (2016 - 2025)
Historic Equity Average for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $177.6 million.
- Angiodynamics' Equity Average fell 734.63% to $177.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $177.6 million, marking a year-over-year decrease of 734.63%. This contributed to the annual value of $194.3 million for FY2025, which is 3345.3% down from last year.
- Latest data reveals that Angiodynamics reported Equity Average of $177.6 million as of Q4 2025, which was down 734.63% from $180.9 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Equity Average ranged from a high of $454.6 million in Q1 2021 and a low of $177.6 million during Q4 2025
- Its 5-year average for Equity Average is $335.7 million, with a median of $402.9 million in 2023.
- In the last 5 years, Angiodynamics' Equity Average skyrocketed by 85.54% in 2023 and then plummeted by 5375.92% in 2024.
- Quarter analysis of 5 years shows Angiodynamics' Equity Average stood at $434.2 million in 2021, then decreased by 5.33% to $411.0 million in 2022, then grew by 0.86% to $414.5 million in 2023, then crashed by 53.76% to $191.7 million in 2024, then dropped by 7.35% to $177.6 million in 2025.
- Its Equity Average was $177.6 million in Q4 2025, compared to $180.9 million in Q3 2025 and $184.4 million in Q2 2025.